- Home
- LEE vs BRNS Comparison
LEE vs BRNS Comparison
Compare LEE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- BRNS
- Stock Information
- Founded
- LEE 1890
- BRNS 2016
- Country
- LEE United States
- BRNS United Kingdom
- Employees
- LEE N/A
- BRNS N/A
- Industry
- LEE Newspapers/Magazines
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- BRNS Health Care
- Exchange
- LEE Nasdaq
- BRNS Nasdaq
- Market Cap
- LEE 53.9M
- BRNS 52.0M
- IPO Year
- LEE N/A
- BRNS 2021
- Fundamental
- Price
- LEE $15.04
- BRNS $1.18
- Analyst Decision
- LEE
- BRNS Strong Buy
- Analyst Count
- LEE 0
- BRNS 2
- Target Price
- LEE N/A
- BRNS $4.00
- AVG Volume (30 Days)
- LEE 58.3K
- BRNS 38.8K
- Earning Date
- LEE 12-05-2024
- BRNS 11-07-2024
- Dividend Yield
- LEE N/A
- BRNS N/A
- EPS Growth
- LEE N/A
- BRNS N/A
- EPS
- LEE N/A
- BRNS N/A
- Revenue
- LEE $616,815,000.00
- BRNS N/A
- Revenue This Year
- LEE N/A
- BRNS $27.18
- Revenue Next Year
- LEE N/A
- BRNS N/A
- P/E Ratio
- LEE N/A
- BRNS N/A
- Revenue Growth
- LEE N/A
- BRNS N/A
- 52 Week Low
- LEE $7.56
- BRNS $1.11
- 52 Week High
- LEE $16.49
- BRNS $5.10
- Technical
- Relative Strength Index (RSI)
- LEE 88.64
- BRNS 42.47
- Support Level
- LEE $8.54
- BRNS $1.15
- Resistance Level
- LEE $14.67
- BRNS $1.35
- Average True Range (ATR)
- LEE 0.74
- BRNS 0.07
- MACD
- LEE 0.78
- BRNS -0.00
- Stochastic Oscillator
- LEE 100.00
- BRNS 19.81
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.